Skip to content

Clinical trials

Terminated Phase 2 Dermatitis, Atopic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dermatitis, Atopic Phase: Phase 2 Status: Terminated Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20072
20091
20111
20141
20172
20186
20197
20201
20216
20223
20234
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated37

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline3
Janssen Research & Development, LLC3
DermBiont, Inc.2
Eli Lilly and Company2
Lakefront Biotherapeutics NV2
Novartis Pharmaceuticals2
Regeneron Pharmaceuticals2
Akesobio Australia Pty Ltd1
Allakos Inc.1
Amgen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dermatitis, Atopic37
Eczema11
Dermatitis7
Immune System Diseases3
Lymphoma, Follicular3
Pruritus3
Skin Diseases2
Inflammation1
Psoriasis1
Skin Diseases, Eczematous1

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.